Efficacy and Safety Analysis of Epoetin Alfa in Patients With Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial The toxicity of allogeneic stem-cell transplantation can be ...

Patient reported outcomes demonstrate favorable health-related quality of life metrics, fewer ICU stays and lower likelihood of rehospitalizations with Orca-T MENLO PARK, Calif., December 06, ...

The study evaluated a reduced-intensity conditioning regimen without total body irradiation for alloHCT in DC/TBD patients. Non-TBI patients showed similar graft failure, GVHD, and overall survival ...

NEW ORLEANS -- A three-drug regimen should be the standard for graft-versus-host disease (GvHD) prophylaxis in blood cancer patients undergoing reduced-intensity conditioning allogeneic hematopoietic ...

Complete remission was induced in 66 patients (88%). With a median follow-up of 35.1 months (range, 13.6 to 47.6 months), 2-year overall and leukemia-free survival were 42% and 40%, respectively.

Please provide your email address to receive an email when new articles are posted on . Peripheral blood stem cells showed similar outcomes to mismatched bone marrow grafts. People of color made up ...

Panelists discuss how transplant eligibility has expanded beyond traditional intensive chemotherapy candidates to include patients receiving lower intensity regimens, with earlier transplant ...